SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: CuttingEdge Bio who wrote (3345)8/1/2021 9:38:01 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3557
 
"pre-exposure prophylaxis " may make people fell safe/secure...and that is not good for overall pandemic control.'
Maybe it is more political than scientific decision.



To: CuttingEdge Bio who wrote (3345)8/2/2021 10:15:47 AM
From: A.J. Mullen  Read Replies (1) | Respond to of 3557
 
That's the reverse of what was stated in the link I posted:

Regeneron said the expanded authorization will help address the needs of immunocompromised people, including those taking immunosuppressive medicines, whose bodies may not mount an adequate response to COVID-19 vaccination.


Please give a link or citation for your take.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News